First Report of Symmetrical Drug-related Intertriginous and Flexural Exanthema (SDRIFE or Baboon Syndrome) After Erenumab Application for Migraine Prevention.

Authors:
Göbel CH; Heinze A; Karstedt S; Cirkel A; Münte TF and 1 more

Journal:
Pain Ther

Publication Year: 2022

DOI:
10.1007/s40122-022-00417-6

PMCID:
PMC9633906

PMID:
35908264

Journal Information

Full Title: Pain Ther

Abbreviation: Pain Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Clinical Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures Hartmut Göbel has received grants, non-financial support, personal fees, and fees to the institution from Amgen, Abbvie, Allergan, Eli Lilly, Lundbeck, Novartis and Teva Pharmaceutical. Axel Heinze reports personal fees from Eli Lilly, Novartis, and Teva Pharmaceutical. Carl H. Göbel, Sarah Karstedt, Anna Cirkel and Thomas Münte have nothing to disclose."

Evidence found in paper:

"Funding No funding or sponsorship was received for this study or publication of this article."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025